Clinical trial
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
NCT02655198 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
- Lead sponsor
- KU Leuven
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- December 31, 2024
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.